UBS analyst Alex Kramm raised the firm’s price target on Cushman & Wakefield to $12 from $9 and keeps a Neutral rating on the shares. The firm says the recovery is “intact,” with Q2 likely just a minor “blip,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CWK:
- Cushman & Wakefield Announces Board Resignation and New Appointments
- Cushman & Wakefield chairman Brett White to retire, Steve Plavin to succeed
- CBRE Group price target raised to $170 from $160 at Morgan Stanley
- Cushman & Wakefield price target raised to $14.50 from $14 at Morgan Stanley
- Cushman & Wakefield Shareholders Approve Key Proposals